Activision Blizzard, Inc. vs Johnson & Johnson: Strategic Comparison

This in-depth comparison examines Activision Blizzard, Inc. and Johnson & Johnson across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Activision Blizzard, Inc. on its own, evaluating Johnson & Johnson, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Activision Blizzard, Inc. and Johnson & Johnson is widest.

On the headline numbers, Activision Blizzard, Inc. reports annual revenue of $7.5B against $94.2B for Johnson & Johnson, while their respective market capitalizations stand at $75.4B and $612.8B. Activision Blizzard, Inc. is headquartered in United States and Johnson & Johnson operates from United States, and those different home markets shape how each company competes.

Activision Blizzard, Inc.: Activision Blizzard is less a single studio than a portfolio of game-making systems: Activision builds high-frequency blockbuster shooters, Blizzard operates deep PC and online universes, and King runs mobile games at global scale. Microsoft bought that portfolio because gaming is increasingly about owned franchises, subscriptions, mobile reach, cloud access, and platform engagement.

Johnson & Johnson: Johnson & Johnson began as a medical-products company in the nineteenth century and became a diversified healthcare giant. After the Kenvue separation, it is a more focused healthcare company centered on medicine and medical technology.

Activision Blizzard, Inc. and Johnson & Johnson pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Activision Blizzard, Inc. and Johnson & Johnson.

Activision Blizzard, Inc. business model: Activision Blizzard makes money from premium game sales, in-game purchases, battle passes, downloadable content, World of Warcraft subscriptions, mobile in-app purchases, advertising, licensing, and platform distribution. Before Microsoft, its strongest model was recurring digital spending around Call of Duty, Blizzard games, and Candy Crush. Inside Xbox, the same assets also support Game Pass, cloud gaming, PC distribution, console engagement, and Microsoft's broader multi-device gaming strategy.

Johnson & Johnson business model: Johnson & Johnson makes money by discovering, developing, manufacturing, and selling prescription medicines and medical technologies. Innovative Medicine sells therapies in oncology, immunology, neuroscience, pulmonary hypertension, infectious disease, and cardiovascular/metabolism. MedTech sells surgery, orthopaedics, cardiovascular, and vision products to hospitals, physicians, and healthcare systems.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Activision Blizzard, Inc. stack up against those of Johnson & Johnson.

Activision Blizzard, Inc. competitive advantage: Activision Blizzard's advantage is the rare combination of a dominant console and PC shooter in Call of Duty, deep Blizzard PC universes such as Warcraft and Diablo, and King's mobile monetization engine through Candy Crush. That mix gives Microsoft durable franchises across console, PC, mobile, cloud, and subscription channels.

Johnson & Johnson competitive advantage: Johnson & Johnson's advantage comes from scale, R&D depth, global regulatory capability, major oncology and immunology franchises, MedTech breadth, and a large commercial infrastructure.

Future prospects matter as much as current results. The growth strategies below explain how Activision Blizzard, Inc. and Johnson & Johnson each plan to expand from here.

Activision Blizzard, Inc. growth strategy: The Microsoft-era strategy is to keep major franchises healthy, expand access across devices, add selected titles to Game Pass, maintain Call of Duty availability on rival platforms, revive Blizzard's China distribution with NetEase, and use King's mobile expertise to reach audiences beyond console and PC.

Johnson & Johnson growth strategy: The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.

A closer look at the financial trajectory of Activision Blizzard, Inc. and Johnson & Johnson rounds out the comparison.

Activision Blizzard, Inc.: The clean financial baseline is FY2022, when Activision Blizzard reported $7.528 billion in net revenues, $1.513 billion in net income, and $8.514 billion in net bookings. Q1 2023 revenue was $2.38 billion and Q2 2023 revenue was $2.21 billion, but Microsoft closed the acquisition before a normal standalone 2023 annual report. Microsoft later reported a $75.4 billion total purchase price for the acquisition in its FY2025 annual report.

Johnson & Johnson: Johnson & Johnson's FY2025 sales increased 6.0% to $94.193 billion. Net earnings rose to $26.804 billion, helped by operating performance and other income items. Innovative Medicine generated $60.401 billion in sales, while MedTech generated $33.792 billion.